CTOs on the Move

Covance

www.covance.com

 
As the drug development business of Laboratory Corporation of America Holdings (LabCorp) and the world’s most comprehensive drug development service company, we have helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today. Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing. Together with our clients, we create solutions that transform potential into reality.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.covance.com
  • 210 Carnegie Center
    Princeton, NJ USA 08540
  • Phone: 609.452.4440

Executives

Name Title Contact Details

Similar Companies

Veterans Evaluation Services

Veterans Evaluation Services is a company that supports the U.S. Department of Veterans Affairs in providing veterans and transitioning service members with the benefits theyve earned through their service to the country. They provide high quality, ti...

Fox Med-Equip Svc

Fox Med-Equip Svc is a Collinsville, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Abortion Advantage

Abortion Advantage is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.

Porex Corporation

Porex Corporation is a Fairburn, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.